A new class of microscopic machines is moving from theory into reality, and it could change how diseases are treated and how ...

Every encounter between a T cell and a potential target—especially when that target is a developing tumor—begins with a rapid ...

Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have ...

Potent drugs like chemotherapy can be life-saving, but often with life-threatening side effects. Notably, they can be indiscriminate, killing both cancer cells and healthy cells in one swoop.

Researchers at the University of Illinois Chicago have identified a molecular switch that helps determine whether cancer ...

A new lipid nanoparticle platform delivers full-length antibodies inside cells, unlocking intracellular targets in cancer, autoimmune disease, and Parkinson’s.

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors in mice while sparing healthy tissue.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while avoiding attack from the body’s own immune defenses. This innovation could ...

The need for new treatments is particularly urgent. Glioblastoma remains among the most lethal cancers, with most patients surviving only around 12 to 18 months after diagnosis. Long-term survival is ...